Literature DB >> 429510

Plasma bradykinin levels and urinary kallikrein excretion in normal renin essential hypertension.

J H Mersey, G H Williams, R Emanuel, R G Dluhy, P Y Wong, T J Moore.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 429510     DOI: 10.1210/jcem-48-4-642

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  6 in total

1.  Early increases in renal kallikrein secretion on administration of potassium or ATP-sensitive potassium channel blockers in rats.

Authors:  T Fujita; I Hayashi; Y Kumagai; N Inamura; M Majima
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Role of urinary alpha1-antitrypsin in Padutin (kallikrein) inactivation.

Authors:  W H Hörl; R M Schäfer; A Heidland
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  [3H]Bradykinin receptor binding in mammalian tissue membranes.

Authors:  R B Innis; D C Manning; J M Stewart; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

4.  Urinary kallikrein excretion in essential and mineralocorticoid hypertension.

Authors:  O B Holland; J M Chud; H Braunstein
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

5.  Converting enzyme activity and essential hypertension.

Authors:  A Overlack; M Higuchi; R Kolloch; K O Stumpe
Journal:  Klin Wochenschr       Date:  1983-04-01

Review 6.  A Novel Category of Anti-Hypertensive Drugs for Treating Salt-Sensitive Hypertension on the Basis of a New Development Concept.

Authors:  Makoto Katori; Masataka Majima
Journal:  Pharmaceuticals (Basel)       Date:  2010-01-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.